Skip to content
value.today
Clearside Biomedical, Inc. logo

Clearside Biomedical, Inc.

CLSD
$92 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$8 M
annual
value.today research
Net income
$-18 M
-233.3% margin
value.today research
Employees
—

Clearside Biomedical, Inc. in brief

Clearside Biomedical, Inc. is a listed company in the Biotechnology industry, based in Georgia, USA. It was founded in 2011. Its last known market value was $92 M (January 2024); there is no current figure. In its latest reported year it had sales of $8 M and a net loss of $18 M.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Clearside Biomedical, Inc. timeline

2 events, 2011–2016
  1. 2011
  2. 🏁
    · approximate
    Founded
  3. 2016
  4. 🔔
    · approximate
    Initial public offering

Events of Clearside Biomedical, Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$41 M$82 M$122 M$163 M20202021202220232024

World rank over time

▼ down 3,730 places since 2020
2020-01-01: #18161#18,16120202021-01-01: #17791#17,79120212022-01-07: #20453#20,45320222022-12-25: #23492#23,49220222023-07-30: #23186#23,18620232024-01-05: #21891#21,8912024

Rank in USA: #3,606 (Jan 2020) · #3,630 (Jan 2021) · #4,087 (Jan 2022) · #4,557 (Dec 2022) · #4,458 (Jul 2023) · #3,752 (Jan 2024)

Annual results

Revenue
$8 M
Operating income
—
Net income
$-18 M

How Clearside Biomedical, Inc. compares in Biotechnology

  • Revenue$8 M · higher than 40% of 647
  • Net margin-233.3% · higher than 24% of 408

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Clearside Biomedical, Inc.🇺🇸$92 M—-233.3%—
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Profile updated:
Nov 15, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Clearside Biomedical, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Clearside Biomedical, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Clearside Biomedical, Inc.? Suggest a correction